Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial

Circulation. Heart failure

Volumn 11, Issue 3, 2018, Pages e004457-

  Lewis, Eldrin F ^a   Claggett, Brian ^a   Shah, Amil M ^a   Liu, Jiankang ^a   Shah, Sanjiv J ^a   Anand, Inder ^a   O'Meara, Eileen ^a   Sweitzer, Nancy K ^a   Rouleau, Jean L ^a   Fang, James C ^a   Desai, Akshay S ^a   Retta, Tamrat M ^a   Solomon, Scott D ^a   Heitner, John F ^a   Stamos, Thomas D ^a   Boineau, Robin ^a   Pitt, Bertram ^a   Pfeffer, Marc A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

echocardiography; heart failure; hospitalization; mortality; spironolactone

Indexed keywords

MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE;

AGED; ANCESTRY GROUP; DRUG EFFECT; FEMALE; HEART; HEART FAILURE; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; HYPERKALEMIA; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; CONTINENTAL POPULATION GROUPS; FEMALE; HEART; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERKALEMIA; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; SPIRONOLACTONE; STROKE VOLUME; TREATMENT OUTCOME;

EID: 85067823647     PISSN: None     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.117.004457     Document Type: Article

References (0)